HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.

Abstract
EBV-associated T/NK-cell lymphoproliferative disease (T/NK-LPD) is defined as a systemic illness characterized by clonal proliferation of EBV-infected T or NK cells. We prospectively enrolled 108 nonimmunocompromised patients with this disease (50 men and 58 women; median onset age, 8 years; age range, 1-50 years) evidenced by expansion of EBV(+) T/NK cells in the peripheral blood; these were of the T-cell type in 64 cases and of the NK-cell type in 44, and were clinically categorized into 4 groups: 80 cases of chronic active EBV disease, 15 of EBV-associated hemophagocytic lymphohistiocytosis, 9 of severe mosquito bite allergy, and 4 of hydroa vacciniforme. These clinical profiles were closely linked with the EBV(+) cell immunophenotypes. In a median follow-up period of 46 months, 47 patients (44%) died of severe organ complications. During the follow-up, 13 patients developed overt lymphoma or leukemia characterized by extranodal NK/T-cell lymphoma and aggressive NK-cell leukemia. Fifty-nine received hematopoietic stem cell transplantation, 66% of whom survived. Age at onset of disease (≥ 8 years) and liver dysfunction were risk factors for mortality, whereas patients who received transplantation had a better prognosis. These data depict clinical characteristics of systemic EBV(+) T/NK-LPD and provide insight into the diagnostic and therapeutic approaches for distinct disease.
AuthorsHiroshi Kimura, Yoshinori Ito, Shinji Kawabe, Kensei Gotoh, Yoshiyuki Takahashi, Seiji Kojima, Tomoki Naoe, Shinichi Esaki, Atsushi Kikuta, Akihisa Sawada, Keisei Kawa, Koichi Ohshima, Shigeo Nakamura
JournalBlood (Blood) Vol. 119 Issue 3 Pg. 673-86 (Jan 19 2012) ISSN: 1528-0020 [Electronic] United States
PMID22096243 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Viral
Topics
  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • DNA, Viral (genetics)
  • Epstein-Barr Virus Infections (complications, pathology, virology)
  • Female
  • Follow-Up Studies
  • Herpesvirus 4, Human (genetics, immunology, isolation & purification)
  • Humans
  • Immunocompromised Host
  • Infant
  • Killer Cells, Natural (immunology, pathology, virology)
  • Lymphoproliferative Disorders (etiology, mortality, pathology)
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Prognosis
  • Prospective Studies
  • Survival Rate
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: